Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

TOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate Cancer (TOPARP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01682772
Recruitment Status : Unknown
Verified August 2019 by Institute of Cancer Research, United Kingdom.
Recruitment status was:  Active, not recruiting
First Posted : September 11, 2012
Last Update Posted : August 15, 2019
Royal Marsden NHS Foundation Trust
Information provided by (Responsible Party):
Institute of Cancer Research, United Kingdom

No Study Results Posted on for this Study
Recruitment Status : Unknown
Actual Primary Completion Date : March 2019
Estimated Study Completion Date : February 2020